AntineoplasticsNo response: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1934卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28435-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：54 / 54

相关论文

共 50 条

[41] DoxorubicinNo response: case report [J].

Reactions Weekly, 2025, 2044 (1) :129-129

[42] InsulinNo response: case report [J].

Reactions Weekly, 2025, 2040 (1) :482-482

[43] AmiodaroneNo response: case report [J].

Reactions Weekly, 2023, 1970 (1) :23-23

[44] MelphalanNo response: case report [J].

Reactions Weekly, 2022, 1925 (1) :304-304

[45] TeduglutideLack of response: case report [J].

Reactions Weekly, 2023, 1969 (1) :339-339

[46] InsulinNo response: case report [J].

Reactions Weekly, 2023, 1938 (1) :750-750

[47] RuxolitinibNo response: case report [J].

Reactions Weekly, 2022, 1893 (1) :298-298

[48] DopamineNo response: case report [J].

Reactions Weekly, 2021, 1839 (1) :118-118

[49] InfliximabLoss of response: case report [J].

Reactions Weekly, 2021, 1844 (1) :231-231

[50] DoxorubicinNo response: case report [J].

Reactions Weekly, 2021, 1883 (1) :156-156

← 1 2 3 4 5 →